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Abstract: Cell penetrating peptides (CPPs) have been successfully used to mediate the intracellular delivery of a wide variety of
molecules of pharmacological interest both in vitro and in vivo, although the mechanisms by which the cellular uptake occurs
remain unclear and controversial. Following our previous work demonstrating that the cellular uptake of the S413-PV CPP occurs
mainly through an endocytosis-independent mechanism, we performed a detailed biophysical characterization of the interaction
of this peptide with model membranes. We demonstrate that the interactions of the S413-PV peptide with membranes are
essentially of electrostatic nature. As a consequence of its interaction with negatively charged model membranes, the S413-PV
peptide becomes buried into the lipid bilayer, which occurs concomitantly with significant peptide conformational changes that
are consistent with the formation of a helical structure. Comparative studies using two related peptides demonstrate that the
conformational changes and the extent of cell penetration are dependent on the peptide sequence, indicating that the helical
structure acquired by the S413-PV peptide is relevant for its nonendocytic uptake. Overall, our data suggest that the cellular
uptake of the S413-PV CPP is a consequence of its direct translocation through cell membranes, following conformational changes
induced by peptide-membrane interactions. Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd.
Keywords: cell penetrating peptide; protein transduction domain; peptide–membrane interaction; tryptophan fluorescence;
circular dichroism; amphipathic alpha helix
INTRODUCTION
Over the last decade, CPPs have attracted a lot of
interest from the scientific community, not only due
to their capacity to translocate across eukaryotic cell
membranes through an elusive temperature-insensitive
and energy-independent mechanism, but mostly due
to the ability of these peptides to mediate the
intracellular delivery of a wide variety of molecules of
pharmacological interest, which has motivated their
extensive use for delivery purposes both in vitro and
in vivo [reviewed in 1–5].
Although the number of peptides described as cell
penetrating has increased considerably during the last
years (both of natural origin and synthetic peptides, e.g.
[6–8]), the high variability of their amino acid sequences
Abbreviations: CPP, cell penetrating peptide; POPC, 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-Phosphocholine; POPG, 1-Palmitoyl-2-Oleoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)]; CD, circular dichroism; HSPG,
heparan sulfate proteoglycan.
* Correspondence to: Maria C. Pedroso de Lima, Departamento de
Bioquı´mica, Faculdade de Cieˆncias e Tecnologia, Universidade de
Coimbra, Apartado 3126, 3001-401 Coimbra, Portugal;
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has hampered the identification of any consensus
sequence. Nonetheless, CPPs are usually short, highly
basic peptides, and in some cases exhibit the ability to
be arranged in amphipathic helical structures. The Tat
and Penetratin peptides, which are derived from the
HIV-1 Tat protein and from the homeodomain of the
Antennapedia protein of Drosophila, respectively [9,10],
as well as the synthetic Pep-1 peptide [11], are among
the best-characterized CPPs.
Despite the extensive research on the ability of
CPPs to traverse cell membranes and promote the
intracellular uptake of various cargo molecules, the
mechanisms underlying the cellular uptake of CPPs,
as well as that of peptide conjugates remain a matter
of extensive debate and controversy. Following several
reports demonstrating that the apparent intracellular
and nuclear accumulation of several CPPs was related
to artifactual observations caused by a redistribution of
membrane-bound peptide molecules upon cell fixation
[12–14], a growing number of studies have shown the
involvement of well-characterized endocytic pathways
in the internalization of several peptides and peptide
conjugates [15–20]. At present, it is clear that these
mechanisms are not mutually exclusive and that
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different peptides rely on distinct mechanisms to enter
cells.
Recently, we have demonstrated that the S413-PV
CPP (ALWKTLLKKVLKAPKKKRKVC), a chimeric peptide
that results from the combination of a sequence derived
from the Dermaseptin S4 peptide with the nuclear
localization signal of the simian virus 40 (SV40) large
T antigen [21], accumulates very efficiently inside cells,
and particularly inside the nucleus, through a rapid,
dose-dependent and nontoxic process, independently
of cell fixation [22,23]. Comparative analysis of peptide
uptake by mutant cells lacking HSPGs showed that the
presence of these negatively charged components at cell
surface markedly facilitates the cellular uptake of the
S413-PV peptide. Most importantly, by applying several
experimental approaches, we have demonstrated that
the main mechanism responsible for the cellular uptake
of the S413-PV peptide is distinct from endocytosis,
most likely involving direct penetration of the peptide
across cell membranes following changes in peptide
conformation induced by the lipid environment [22,23].
Aiming at understanding the sequence of events
that are on the basis of this translocation process,
we performed a detailed biophysical characterization
of the interaction of the S413-PV CPP with model
membranes of different phospholipid composition and
charge density. The results presented here demonstrate
that the initial interaction of the S413-PV CPP with
the target membranes is of electrostatic nature, and
hence highly dependent on the content of negatively
charged components on the target membrane. As a
consequence of this peptide–membrane interactions,
significant changes of both the intrinsic fluorescence
and dynamics of the S413-PV peptide are observed.
Concomitantly, an increase in the helical content of
the S413-PV peptide was observed, indicating that
upon interaction with the target membranes, the
peptide undergoes significant conformational changes.
Comparative analysis using two related peptides
demonstrates that the conformational changes are
dependent on the peptide sequence, suggesting that the
alpha-helical structure acquired by the S413-PV peptide




High purity (>95%) S413-PV peptide (ALWKTLLKKVLKAP-
KKKRKVC), reverse NLS peptide (ALWKTLLKKVLKAVKRK-
KKPC) and scrambled peptide (KTLKVAKWLKKAKPLRKLVKC)
were obtained from Thermo Electron (Thermo Electron GmbH,
Germany). During synthesis, peptides were either fluorescently
labeled with 5-(6)-tetramethylrhodamine (TAMRA), or modified
with an acetyl group at the N-terminus, and further modified
by introducing an amide group at the C-terminus. Freeze-dried
peptides were reconstituted in high purity water.
Peptide concentration was determined by amino acid
analysis and light absorption at 280 nm. Amino acid analysis
was performed in a Beckman 6300 automatic analyzer,
following acid hydrolysis of the peptides.
Liposome Preparation
Large unilamellar vesicles were prepared by extrusion of
multilamellar vesicles composed of POPC (Avanti Polar Lipids,
Alabaster, USA), POPG (Avanti), or mixtures of these two
lipids at different molar ratios [(POPC : POPG (50 : 50) and
POPC : POPG (80 : 20)].
Lipid solutions in chloroform were mixed at the desired
molar ratios, and dried under vacuum, at room temperature,
using a rotary evaporator. The dried lipid films were then
hydrated with 1.0 ml high purity water, and the multilamellar
vesicles obtained were briefly sonicated and extruded 21
times through two-stacked polycarbonate filters (100 nm pore
diameter) using a Liposofast device (Avestin, Toronto, Canada).
Total lipid concentrations of the resulting lipid vesicles were
determined by the Bartlett method [24], and 10 mM stock
solutions of the different liposome formulations were prepared.
Steady-state Fluorescence Spectroscopy
Steady-state fluorescence measurements were performed in a
SPEX Fluorolog 2 spectrofluorometer, at room temperature,
using 10 × 2 or 5 × 5 mm quartz cuvettes.
Interaction of S413-PV peptide with lipid vesicles was
assessed by following peptide intrinsic fluorescence upon
sequential addition of small volumes of concentrated vesicle
stock solutions to peptide samples, up to a lipid/peptide
molar ratio of 40. Experiments were performed in 10 mM
sodium phosphate buffer (pH 7.0). The concentration of S413-
PV peptide, as well as that of monomeric L-tryptophan, which
was used as control, was 2.5 µM. Excitation wavelength was
280 nm and fluorescence emission was scanned from 300 to
400 nm.
All spectra were corrected for background contributions of
buffer, and of different concentrations of vesicles. Spectra were
not corrected for the photomultiplier wavelength dependence.
Tryptophan Fluorescence Quenching Experiments
Quenching of tryptophan fluorescence by acrylamide was
evaluated in aqueous buffer, in the presence or absence of
lipid vesicles, at different lipid/peptide molar ratios.
The Stern-Volmer quenching constants (KSV ) for the S413-
PV peptide and monomeric L-tryptophan were determined by
linear regression using the Stern-Volmer equation [25,26]:
F0
F
= 1 + KSV [Q] (1)
where F0 and F are the fluorescence intensities of tryptophan
emission in the absence and presence of the quencher,
respectively, and [Q] is the molar concentration of the
quencher in the sample.
Emission spectra of the S413-PV peptide (2.5 µM) and of
monomeric L-tryptophan (2.5 µM) were acquired as described
previously, in the presence of different acrylamide concen-
trations (5–100 mM). Acrylamide was added from a 1.0 M
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aqueous stock solution. Spectra were corrected for back-
ground fluorescence of buffer, vesicles and different concen-
trations of acrylamide. Spectra were additionally corrected
for the inner filter effect, as described elsewhere [27], con-
sidering ε280 nm(acrylamide) = 3 M−1 cm−1 and ε280 nm(trp) =
5690 M−1 cm−1.
Time-resolved Fluorescence Spectroscopy
Time-resolved fluorescence measurements of S413-PV peptide
(5 µM) in the presence of POPG vesicles, at a lipid/peptide
molar ratio of 10, were performed in 10 mM sodium phosphate
buffer, pH 7.0. The time-resolved instrumentation (correlated
single-photon timing technique) was described previously [28].
Excitation wavelength was 287 nm and emission was detected
at the magic angle (54.7°) relative to the vertically polarized
beam. The number of counts on the peak channel was 20 000
and the number of channels per curve used for analysis was
800. Data analysis was carried out using a nonlinear, least-
square iterative convolution method based on the algorithm of
Marquardt [29]. The goodness of the fit was judged from the
reduced χ2, weighted residuals and autocorrelation plots.
More than one component was required to describe the
decay of tryptophan fluorescence in the peptide,
I(t) =
∑
αi exp(−t/τi ) (2)
and in this case, the average lifetime τ of a fluorophore is







where ai are the normalized preexponentials (amplitudes) and
τi the lifetime components.
The time-resolved fluorescence anisotropies were deter-
mined using Glan-Thompson polarizers, and calculated
according to:
r(t) = IVV(t) − GIVH(t)
IVV(t) + 2GIVH(t) (4)
where the different intensities are the vertical (IVV) and
horizontal (IVH) components of the fluorescence emission with
excitation vertical to the emission axis. The intensity decays of
polarized light IVV(t) and IVH(t) were obtained with the same
accumulation time. The instrumental factor G for the time-
resolved instrumentation is 1, once a scrambler is used before
the detector.
Circular Dichroism Spectroscopy
CD spectra were acquired in a Jasco J-715 spectropolarimeter
using 1.0 mm quartz cuvettes. Experiments were performed
at 15 °C, in 10 mM sodium phosphate buffer (pH 7.0), or 20%
trifluoroethanol (TFE) in the same buffer. Five spectra were
collected and averaged for each sample. Peptide concentrations
ranged from 5 to 50 µM, and maximal lipid concentration
was 0.2 mM. All spectra were corrected for background
contributions of buffers and lipid vesicles, and smoothed using
the Jasco J-715 noise reduction software.
To facilitate interpretation of CD spectra, the relative
contribution of three secondary structure elements (α-helix,
β-structure and random coil) to the overall structure of the
peptide was estimated by computer fitting of the spectra
according to the algorithm convex constraint analysis (CCA).
Cells
HeLa cells (human epithelial cervical carcinoma) were main-
tained at 37 °C, under 5% CO2, in Dulbecco’s modified Eagle’s
medium (DMEM)/high glucose (DMEM; Sigma, St. Louis, MO)
supplemented with 10% (v/v) heat-inactivated fetal bovine
serum (Biochrom KG, Berlin, Germany), and with 100 units
penicillin and 100 µg/ml streptomycin.
Peptide Cellular Uptake Studies
For experiments on peptide uptake, 0.8 × 105 HeLa cells/well
were seeded onto 12-well plates (flow cytometry) or a 12-well
plate containing 16-mm glass coverslips (confocal microscopy),
24 hours prior to incubation with the peptide. The cells
were then washed with phosphate-buffered saline (PBS) and
incubated with 1.0 µM of S413-PV peptide, reverse NLS peptide
or scrambled peptide, in serum-free DMEM, for 30 minutes
at 37 °C. Analysis of peptide internalization was performed by
confocal laser-scanning microscopy and flow cytometry.
For analysis of the subcellular localization of the peptides
by confocal microscopy, following peptide-cell incubation, the
cells were washed and mounted in PBS, and immediately
visualized. All observations were performed using live cells, in
a Zeiss LSM510 laser-scanning microscope.
Flow cytometry analysis was performed in live cells,
using a Becton Dickinson FACSCalibur flow cytometer. Data
were obtained and analyzed using CellQuest software (BD
Biosciences). After incubation with the different peptides, cells
were washed once with PBS and trypsinized (10 minutes at
37 °C) to remove extracellular, surface-bound peptide. The
cells were then further washed, resuspended in PBS, and
immediately analyzed. Live cells were gated by forward/side
scattering from a total of 10 000 events.
RESULTS
Extent of Interaction of S413-PV Peptide with Target
Membranes is Dependent on Membrane Charge
Density
To characterize the interaction of the S413-PV peptide
with membranes, changes in the intrinsic fluorescence
of the peptide, which results from a single tryptophan
residue located at the N-terminus (aa 3), were analyzed
in the presence of lipid vesicles of different charge
densities (neutral POPC vesicles and negatively charged
POPC : POPG (80 : 20), POPC : POPG (50 : 50) or POPG
vesicles).
In aqueous buffer, the wavelength of maximal
fluorescence emission observed for the S413-PV peptide
(λem) was 354 nm (Figure 1(A)), a result similar to that of
monomeric L-tryptophan under the same experimental
conditions (data not shown).
Upon interaction with the negatively charged vesicles,
a clear change of maximal fluorescence emission of the
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S413-PV peptide toward shorter wavelengths (blue shift)
was observed, as a function of the lipid/peptide molar
ratio (λem = 324 nm in the presence of POPG vesicles,
L/P ≥ 8), concomitantly with a significant increase of
fluorescence intensity (Figure 1(A)).
On the basis of the increase in the fluorescence
quantum yield of tryptophan observed upon interaction
with the negatively charged membranes (Figure 1(B)),
the extent of interaction, as assessed from the
lipid/water partition coefficient which can be described
by,
Kp = nL/VLnW/VW (5)
where ni stands for mols of peptide in phase i and
Vi for volume of the phase, can be determined. The
phase is either aqueous (i = W) or lipidic (i = L). The
relationships and assumptions used to determine the
partition coefficient (Kp) were previously described [30],
I = IW + ILKpV L[L]
1 + KpV L[L]
(6)
where I is the fluorescence intensity for each lipid
concentration [L], and Ii, the values in phase i (i = W,
L). The lipid molar volume V L = 0.637 dm3 M−1 used in
this work is obtained from extrapolation of available
data in the literature [31].
A nonlinear fit of Eqn (6) to the data (Figure 1(B))
yields the values of IL and Kp. The partition coeffi-
cients calculated for the S413-PV peptide in the pres-
ence of vesicles composed of POPC : POPG (80 : 20),
POPC : POPG (50 : 50) and POPG were 0.23 × 105, 1.17 ×
105 and 1.96 × 105, respectively, clearly indicating that
Figure 1 (A) Effect of target membranes on the intrinsic fluorescence of the S413-PV peptide. Spectra were acquired in sodium
phosphate buffer, pH 7.0 (dashed line; buffer), or in the presence of negatively charged vesicles composed of POPG (solid lines;
lipid/peptide molar ratios are indicated in the figure). Excitation wavelength was 280 nm and fluorescence emission was scanned
from 300 to 400 nm. (B) Partition of S413-PV peptide into lipid vesicles of different composition. Changes of peptide fluorescence
intensity induced by the different lipid vesicles were used to calculate the partition coefficients (Kp), by a nonlinear regression
fitting using Eqn (6). Excitation wavelength was 280 nm and fluorescence emission was scanned from 300 to 400 nm. Partition
coefficients calculated in the presence of different vesicles (except POPC) are displayed in panel (C). (C) Effect of membrane charge
density on the partition coefficient of the S413-PV peptide.
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the extent of peptide–membrane interactions is depen-
dent on the density of negatively charged components
in the target membranes (Figure 1(C)).
At low lipid/peptide molar ratios, the magnitude
of the blue shift of maximal fluorescence emission
of the S413-PV peptide induced by the negatively
charged vesicles, increased with the charge density of
the membranes (POPC : POPG (80 : 20) < POPC : POPG
(50 : 50) < POPG), as well as with lipid/peptide ratio
(Figure 2; Table 1). As expected, at higher lipid/peptide
ratios, the difference between the magnitudes of the
blue shifts induced by the different negatively charged
vesicles was progressively less pronounced, the shifts
being comparable at lipid/peptide molar ratios of 40, or
higher (Figure 2; Table 1).
No changes in the fluorescence emission spectra of
the S413-PV peptide were observed in the presence of
neutral lipid vesicles composed of POPC, even at high
lipid/peptide molar ratios (Figure 2; Table 1).
Overall, the observed spectral changes clearly indi-
cate that the interaction of the S413-PV peptide with
membranes is essentially of electrostatic nature. More-
over, the shift of peptide maximal fluorescence toward
shorter wavelengths observed in the presence of neg-
atively charged vesicles indicates that, following its
interaction with these vesicles, the S413-PV peptide
becomes localized in a highly hydrophobic environ-
ment.
Figure 2 Effect of target membrane composition and
lipid/peptide molar ratio on the wavelength of maximal
fluorescence emission of the S413-PV peptide. Spectra of
S413-PV peptide were obtained in the presence of lipid vesicles
composed of POPC (), POPC : POPG (80 : 20) (), POPC : POPG
(50 : 50) (ž) or POPG (♦), at different lipid/peptide molar ratios.
Spectra were acquired in sodium phosphate buffer, pH 7.0;
excitation wavelength was 280 nm and fluorescence emission
was scanned from 300 to 400 nm.
Table 1 Effect of the target membrane on the intrinsic
fluorescence of S413-PV peptide and its quenching by
acrylamide, as a function of lipid/peptide ratio. Results
obtained for monomeric L-tryptophan, which was used as
control, are shown for comparison. Stern-Volmer quenching
constants (KSV ) were calculated by fitting Eqn (1) to the
experimental data, as described in Materials and Methods
L/Pa λem (nm)b KSV (M−1)
L-tryptophan
buffer, pH 7.0 — 356 18.5 ± 0.2
POPG 40 356 19.6 ± 0.2
S413-PV peptide — —
buffer, pH 7.0 — 354 15.7 ± 0.3
POPC 40 354 14.8 ± 0.7
POPC : POPG (80 : 20) 10 343 8.7 ± 0.4
POPC : POPG (80 : 20) 20 334 5.7 ± 0.4
POPC : POPG (80 : 20) 40 328 2.3 ± 0.2
POPC : POPG (50 : 50) 40 326 2.1 ± 0.1
POPG 40 324 3.1 ± 0.2
a Molar ratio of lipid to monomeric L-tryptophan or S413-PV
peptide.
b Wavelength of maximal fluorescence emission.
S413-PV Peptide Becomes Buried into the Lipid
Bilayer as a Consequence of its Interaction with
Negatively Charged Membranes
To evaluate the degree of exposure of the peptide to
the aqueous environment following its interaction with
membranes, the extent of quenching of tryptophan
fluorescence by the neutral hydrophilic quencher
acrylamide was determined.
Quenching efficiency of the intrinsic fluorescence of
the S413-PV peptide by acrylamide in the presence of
POPC phospholipid vesicles was comparable to that
in buffer (Figure 3(A), Table 1), demonstrating that the
S413-PV peptide remains completely exposed to the
aqueous environment. Conversely, following interaction
of the peptide with negatively charged vesicles, a
significant decrease in the efficiency of quenching by
acrylamide was observed; at a lipid/peptide molar
ratio of 40, a ratio at which maximal blue shifts
were observed, quenching was minimal (Figure 3(A),
Table 1). As illustrated by the results obtained with the
vesicles composed of POPC : POPG (80 : 20), quenching
efficiency decreased with increasing lipid/peptide molar
ratios (Figure 3(B), Table 1), as expected by the increase
in the fraction of peptide incorporated into the
membrane.
Quenching of monomeric L-tryptophan, which was
used as control, was similar in buffer and in the pres-
ence of negatively charged POPG vesicles (Figure 3(A);
Table 1).
It should be stressed that the KSV in Table 1,
are the product of the bimolecular quenching rate
constant by the fluorescence lifetime. Since the
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Figure 3 Stern-Volmer plots of acrylamide quenching of
the intrinsic fluorescence of monomeric L-tryptophan and
S413-PV peptide. (A) Effect of target membrane composition.
Quenching of S413-PV peptide fluorescence was evaluated in
buffer, as well as in the presence of neutral lipid vesicles
composed of POPC, or negatively charged vesicles composed
of POPC : POPG (80 : 20), POPC : POPG (50 : 50) or POPG, at a
lipid/peptide ratio of 40. Results of quenching of monomeric
L-tryptophan (L-Trp) in buffer and in the presence of POPG
vesicles, at a lipid/peptide ratio of 40, are shown for
comparison. (B) Effect of lipid/peptide molar ratio. Quenching
of intrinsic fluorescence of S413-PV peptide was evaluated
in the presence of POPC : POPG (80 : 20) lipid vesicles, at the
indicated lipid/peptide molar ratios. Fluorescence quenching
was assessed, following addition of different amounts of
acrylamide from a 1.0 M stock solution. Spectra were acquired
in sodium phosphate buffer, pH 7.0; excitation wavelength
was 280 nm and fluorescence emission was scanned from
300 to 400 nm. Stern-Volmer quenching constants (KSV ) were
calculated by fitting Eqn (1) to the experimental data, as
described in Materials and Methods (results are summarized
in Table 1).
quantum yields and lifetimes increase upon interaction
of the peptide with the membranes, higher KSV values
would be expected. From the significant decrease
observed, it can be concluded that the ruling factor
is, in fact, the shielding of the tryptophan to the
aqueous environment, and thereby to the acrylamide
quencher. Therefore, these results are in agreement
with those described above regarding the changes
in the fluorescence emission spectra of the S413-PV
peptide, which collectively demonstrate that the S413-
PV peptide, or at least the region of the peptide that
contains the tryptophan residue, becomes less exposed
to the aqueous environment following its interaction
with negatively charged membranes, most likely being
inserted into the lipid bilayer.
Dynamics of S413-PV Peptide is Reduced upon
Interaction with Negatively Charged Membranes
The starting point of the analysis of time-resolved
anisotropy, from which dynamic information can be
obtained, involves the measurement of the fluorescence
decay obtained under the magic angle conditions.
The fluorescence decay of the S413-PV peptide in
the presence of POPG vesicles was described by two
components, the lifetimes and amplitudes Eqn (2)
being τ1 = 1.41 ns (α1 = 0.537) and τ2 = 3.23 ns. The
existence of two or even three components for the
fluorescence decay of tryptophan is very common and,
among other factors, usually attributed to the existence
of several rotational conformers of the indole ring [32].
The mean fluorescence lifetime, as determined from
Eqn (3), τ = 2.62 ns, is a value common for a peptide
interacting with a membrane model system. These
data, as well as those for the anisotropy described
below, are not biased by any contribution of peptide
in water, since the experiments were carried out at a
lipid concentration of 50 µM, and considering the very
high value for Kp, the molar fraction of peptide in water
(which in addition has a smaller quantum yield), is
xW = 0.0045.
For the time-resolved anisotropy data, at least two
rotational correlation times (θi), and a constant (r∞),
were needed to describe the experimental decay Eqn (7),
r(t) = (ro − r∞) × [β1 exp(−t/θ1) + β2 exp(−t/θ2)] + r∞
(7)
where ro is the fundamental anisotropy, and βi is
the amplitude associated to each decay component.
Although analysis of the data in which each component
of the magic angle fluorescence intensity decay is
associated to one rotational correlation time was also
performed, no statistically meaningful parameters were
recovered from such type of analysis, and therefore a
nonassociative model was used.
The experimental decay is shown in Figure 4, and
from the fitting of Eqn (7) to the data, the following
parameters were recovered: ro = 0.2, r∞ = 0.12, θ1 =
0.252 ns (β1 = 0.414) and θ2 = 6.93 ns. The obtained
fundamental anisotropy or anisotropy at zero time, ro, is
the same as that reported by Valeur and Weber in rigid
media [33]. This means that there are no additional
ultrafast dynamics below the time resolution of the
instrumentation (subpicosecond), which is compatible
with a peptide strongly immobilized at the membrane;
the existence of a limiting anisotropy r∞, which is
an evidence of a restricted motion of the tryptophan
fluorophore on the timescale of the fluorescence decay,
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Figure 4 Anisotropy decay of S413-PV peptide in the
presence of POPG vesicles. Decay of S413-PV peptide (5 µM)
was evaluated in sodium phosphate buffer, pH 7.0, in the
presence of negatively charged vesicles composed of POPG, at
a lipid/peptide molar ratio of 10. Anisotropy parameters were
obtained by fitting Eqn (7) to the experimental data.
is a further evidence for this situation. Interestingly,
the value of 0.12 obtained for r∞ is higher than
the ones found for transmembrane peptides [34], but
similar to those found for basic peptides in electrostatic
interaction with negatively charged membranes [35].
Since the longer rotational correlation time θ2, is more
than one order of magnitude higher than the shorter
one, θ1, the total anisotropy can be interpreted as the
product of two independent depolarizing processes: a
first one owing to faster movements of the peptide
segment containing the tryptophan residue (with an
associated correlation time ϕsegmental), and a second one
related to the global rotational motion of the whole
peptide (described by ϕglobal) [36],
θ2 = ϕglobal (8)
θ1 = ϕsegmental ϕglobal
ϕsegmental + ϕglobal (9)
In this way, the time-dependent anisotropy decay can
be described by Eqn (10),
r(t) = r(0) [(1 − S12) exp(−t/ϕsegmental) + (1 − S22)S12
× exp(−t/ϕglobal) + S12S22
]
(10)
where S1 and S2 are the order parameters associated,
respectively, to the segmental and global peptide
dynamics. Values of S1 = 0.92 and S2 = 0.83 were
obtained. In the framework of the ‘wobbling in cone
model’ [37], the maximum cone angles α, are given
by cosαi = 1/2[(8Si + 1)1/2 − 1], and for this peptide,
values of α1 = 21° and α2 = 28° were obtained. Both
these values are very small, and specifically the first
one, which is associated to the local movements of the
tryptophan residue, points out that this part of the
peptide is very rigid. In this context, the presence of a
lysine near the tryptophan should be stressed, which
probably anchors this extreme of the peptide to the
negatively charged lipids.
Altogether, these results provide evidence that the
dynamics of the S413-PV peptide is significantly reduced
owing to its strong interaction with negatively charged
membranes.
S413-PV Peptide Undergoes Significant
Conformational Changes upon Interaction with
Negatively Charged Target Membranes
CD experiments were performed to determine if the
interaction of the S413-PV peptide with membranes
induces changes of peptide conformation. Analysis of
CD spectra of the S413-PV peptide in buffer demon-
strated that the peptide is completely unstructured
in aqueous solution (Figure 5(A)). In the presence of
vesicles composed of POPC, the CD spectra of the S413-
PV peptide were indistinguishable from that obtained
in buffer, independently of the lipid/peptide molar
ratio, demonstrating that no conformational changes
are induced by neutral membranes (Figure 5(A)). In
contrast, clear changes in the CD spectra of the S413-
PV peptide were observed in the presence of vesicles
containing negatively charged phospholipids, demon-
strating that interaction of the peptide with these
vesicles results in prominent changes in its secondary
structure (Figure 5(B), (C), Table 2).
At the lowest lipid/peptide molar ratio examined
(L/P = 4), the extent of peptide conformational changes
was highly dependent on the membrane charge
density (Figure 5(B), Table 2). At this lipid/peptide
ratio, the interaction of the S413-PV peptide with
the POPG vesicles resulted in significant changes of
peptide conformation, whereas considerably smaller
Table 2 Effect of target membrane composition and
lipid/peptide ratio on the secondary structure of the S413-PV
peptide. Fitting of CD spectra was performed according to the
CCA algorithm (refer to Materials and Methods)
L/Pa Random α-helix β-structure
Buffer, pH 7.0 — 0.98 0.00 0.02
POPC 4 1.00 0.00 0.00
8 0.98 0.00 0.02
32 1.00 0.00 0.00
POPC : POPG (80 : 20) 4 1.00 0.00 0.00
8 0.98 0.00 0.02
16 0.82 0.05 0.13
32 0.70 0.28 0.02
POPC : POPG (50 : 50) 4 0.81 0.18 0.01
8 0.42 0.22 0.36
POPG 4 0.29 0.29 0.42
a Molar ratio of lipid to S413-PV peptide.
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Figure 5 Circular dichroism analysis of S413-PV peptide conformational changes induced in the presence of (A) neutral vesicles,
or (B,C) negatively charged vesicles. CD spectra of S413-PV peptide were acquired in sodium phosphate buffer, pH 7.0, in the
presence of neutral target membranes composed of POPC, or negatively charged vesicles composed of POPC : POPG (80 : 20),
POPC : POPG (50 : 50) or POPG, at the indicated lipid/peptide molar ratios, as described in Materials and Methods. Spectra in
panel (C) correspond to the maximal lipid/peptide ratios tested for each of the negatively charged vesicle formulations tested. The
relative contribution of three secondary structure elements (α-helix, β-structure and random coil) to the overall structure of the
peptide was estimated by computer fitting (results are summarized in Table 2).
changes were observed in the presence of vesicles
composed of POPC : POPG (50 : 50) and POPC : POPG
(80 : 20). Nonetheless, significant changes of peptide
conformation were achieved in the presence of vesicles
composed of mixtures of POPC and POPG, although at
higher lipid/peptide molar ratios (Figure 5(C), Table 2),
as illustrated by the observation that the peptide
conformational changes induced by vesicles composed
of POPG at a lipid/peptide ratio of 4 were similar to
those induced by POPC : POPG (50 : 50) vesicles at a
lipid/peptide ratio of 8, and slightly more pronounced
than those observed for POPC : POPG (80 : 20) vesicles
at the highest lipid/peptide molar ratio examined
(L/P = 32) (Figure 5(C), Table 2).
Overall, analysis of the obtained CD spectra indicates
that the changes in peptide conformation induced upon
interaction with the different negatively charged vesicles
are consistent with an increase in the contribution of
an alpha-helical structural component (Table 2).
Peptide Secondary Structure Induced by Negatively
Charged Membranes is Dependent on Peptide
Sequence
To elucidate whether the S413-PV peptide sec-
ondary structure is a consequence of specific pep-
tide–membrane interactions, or rather the outcome
of nonspecific interactions of electrostatic nature, CD
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experiments were performed using two control pep-
tides generated on the basis of the S413-PV peptide
sequence, named reverse NLS peptide and scrambled
peptide. In the reverse NLS peptide, the sequence cor-
responding to the SV40 NLS is inverted, whereas the
scrambled peptide has a distinct (random) primary
sequence (Figure 6(A)).
Similarly to what was previously observed for the
S413-PV peptide, the reverse NLS and scrambled
peptides are completely unstructured in aqueous buffer
(Figure 6(B), (C)).
Analysis of the CD spectra of the three peptides in
20% TFE, an apolar solvent that mimics the hydropho-
bic environment of a lipid bilayer, demonstrated that
the peptides exhibit comparable propensities to be
arranged as alpha-helical structures (Figure 6(B)).
Interestingly, the conformational changes of the
scrambled peptide induced upon its interaction with the
negatively charged membranes composed of POPG were
significantly less pronounced than those observed for
the S413-PV and reverse NLS peptides, and no increase
of an alpha-helical structural component was detected
for the scrambled peptide (Figure 6(C)).
Since the three peptides have similar physicochem-
ical properties (peptide length, mass and charge) and
similar propensities to form alpha-helical structures,
the distinct behavior observed for the scrambled pep-
tide in the presence of negatively charged vesicles
clearly demonstrates that the conformational changes
induced by the membranes are dependent on the pep-
tide sequence. Moreover, these results demonstrate that
the N-terminal sequence of the S413-PV peptide (which
is maintained in the reverse NLS peptide, but absent in
the scrambled peptide) is responsible for the formation
of the alpha-helical structure.
Amino Acid Sequence Determines the Extent and
Mechanism of Peptide Cellular Uptake
To clarify if the different mode of interaction of the
peptides with model membranes, which leads to distinct
peptide conformational changes, correlates with a
different ability of the peptides to translocate across
cell membranes, a comparative analysis of the cellular
uptake of the S413-PV, reverse NLS and scrambled
peptides was performed by flow cytometry and confocal
microscopy.
Although the S413-PV and its derivative peptides
have similar physicochemical properties, the extent of
cellular uptake of the scrambled peptide, as assessed
by flow cytometry, was less efficient than that observed
for the S413-PV and reverse NLS peptides (Figure 7(A)).
Most importantly, confocal fluorescence microscopy
analysis revealed distinct subcellular localizations of
the peptides: the S413-PV and reverse NLS peptides
were distributed throughout the cytoplasm and nucleus
of cells (accumulation in the nucleoli was sometimes
Figure 6 Effect of peptide sequence on the conforma-
tional changes induced by negatively charged membranes.
(A) Sequences of S413-PV, reverse NLS and scrambled pep-
tides. The reverse NLS and scrambled peptides have an amino
acid composition and overall charge identical to the S413-PV
peptide; in the reverse NLS peptide, the sequence correspond-
ing to the SV40 NLS is inverted; the scrambled peptide has
a random primary sequence. (B) Effect of solvent polarity on
peptide secondary structure. Circular dichroism analysis of
the S413-PV ( ), reverse NLS (- - - - ) and scrambled pep-
tides (· · · ·) was performed in aqueous buffer (thin lines; polar)
or in 20% trifluoroethanol (TFE) (thick lines; apolar, ‘mem-
brane-mimicking’ environment), as described in Materials and
Methods. (C) Effect of negatively charged membranes on pep-
tide secondary structure. Circular dichroism analysis of the
S413-PV ( ), reverse NLS (- - - - ) and scrambled peptides
(· · · ·) was performed in buffer (thin lines) or in the presence
of negatively charged membranes composed of POPG (thick
lines; L/P = 4), as described in Materials and Methods.
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evident), whereas the scrambled peptide presented an
exclusively punctated cytoplasmic distribution, which
is characteristic of an endocytic uptake mechanism
(Figure 7(B)).
The results obtained clearly indicate that the
peptide–membrane interactions that occur following
peptide binding to cells, particularly the peptide
conformational changes, determine the mechanism
by which the cellular uptake of the peptide occurs,
and ultimately its intracellular fate. Moreover, these
observations demonstrate that the conformational
changes observed for the S413-PV peptide are crucial
for its ability to efficiently translocate across cell
membranes.
DISCUSSION
Previous studies have demonstrated that the cellular
uptake of some CPPs, including the S413-PV peptide,
occurs mainly through a mechanism distinct from
endocytosis, strongly suggesting the involvement of a
physical process dependent on the direct interaction
of such peptides with biological membranes. The
main goal of the work described here was the
detailed biophysical characterization of the interaction
of the S413-PV peptide with model membranes, aiming
at gaining insights into the molecular mechanisms
responsible for the ability of this peptide to translocate
across biological membranes.
Comparative analysis of the interaction of the S413-
PV peptide with the model membranes of different phos-
pholipid compositions demonstrated that the extent of
peptide–membrane interactions is dependent on the
presence of negatively charged membrane components,
providing evidence that the interactions established
between the S413-PV peptide and the membranes
are essentially of electrostatic nature. As a conse-
quence of these interactions, clear changes in the
intrinsic fluorescence spectra of the S413-PV peptide
could be detected, namely an increase in the fluo-
rescence intensity and a shift of the wavelength of
maximal emission toward shorter wavelengths (blue
shift), both indicative of changes in the hydropho-
bicity of the peptide environment. A detailed anal-
ysis of these spectral changes highlighted a direct
correlation between the partition coefficient of the
S413-PV peptide into the target membranes and the
relative amount of negatively charged membrane com-
ponents.
Figure 7 Cellular uptake of S413-PV, reverse NLS and scrambled peptides. (A) Flow cytometry quantification and (B) confocal
microscopy analysis of peptide uptake. HeLa cells were incubated for 1 hour, at 37 °C, with 1.0 µM of rhodamine-labeled S413-PV,
reverse NLS or scrambled peptides. The cells were then either immediately observed by confocal fluorescence microscopy,
or analyzed by flow cytometry following cell treatment with trypsin, to remove noninternalized, surface-bound peptide. All
experiments were performed in live cells.
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The magnitude of the blue shift described here for the
S413-PV peptide in the presence of negatively charged
vesicles composed of POPG, at a lipid/peptide molar
ratio of 40 (from 354 to 324 nm), is remarkable when
compared to those observed for other CPPs, such as
the Penetratin and Transportan peptides (for which
shifts of peptide fluorescence to approximately 340 nm
were reported [38–40]), or the Pep-1 peptide (showing
a blue shift of 20 nm [41]). In fact, the wavelength
of maximal fluorescence emission of the S413-PV
peptide, observed in the presence of negatively charged
vesicles (324 nm in the case of POPG; uncorrected
spectra), is comparable to those classically reported
for tryptophan residues that are fully protected from
the aqueous environment, such as those found at
the extremely hydrophobic environments of the core
of several proteins [25].
In agreement with the pronounced spectral changes
observed, the S413-PV peptide, or at least the region
of the peptide that contains the tryptophan residue,
becomes considerably less exposed to the aqueous
milieu as a consequence of its interaction with
negatively charged membranes.
Although the extent of partitioning of the S413-PV
peptide into the target membranes was dependent
on the composition of the target membrane, it is
interesting to note that, at the highest lipid/peptide
molar ratio tested (L/P = 40), the magnitude of the blue
shifts observed, as well as the calculated KSV , were
comparable. These data demonstrate that, irrespective
of the charge density of the target membrane, the
interaction of the S413-PV peptide with the negatively
charged membranes leads to a localization of the
peptide into an extremely hydrophobic environment,
most likely buried into the hydrophobic lipid bilayer.
Supporting these results, data from time-resolved
fluorescence anisotropy showed a strong reduction of
the dynamics of the S413-PV peptide upon interaction
with negatively charged membranes.
Results from CD experiments demonstrated that the
interaction of the S413-PV peptide with the negatively
charged vesicles also induces significant changes in
the secondary structure of the peptide. Whether these
conformational changes are a prerequisite for peptide
insertion into the lipid bilayer, or a consequence of
this process, remains to be elucidated. Conformational
changes induced upon interaction with the negatively
charged membranes have also been reported for
other peptides that have shown to translocate across
biological membranes, such as the Penetratin and
Pep-1 peptides [39,41,42].
Although the quantitative analysis of the relative
contribution of different structural components to the
CD spectra should always be regarded with caution,
our results reveal a general trend toward an increase
in the alpha-helical structural motif with increasing
membrane charge density and lipid/peptide molar
ratio. Although the analysis of the CD spectra indicated
the contribution of a beta structural component under
some experimental conditions, these results most likely
reflect the limited ability of this type of analysis to
distinguish beta-type topology from random coil.
In the face of the results showing that the S413-
PV peptide evolves from a random coil in aqueous
solution to an alpha helix upon interaction with
negatively charged membranes, it would be tempting
to rationalize the data obtained from the anisotropy
analysis, regarding to the global movement of an
alpha helix. Although the formalisms are available (e.g.
the dependence of the diffusion coeffient D⊥ on the
molecular geometry such as a rigid rod, as described
by Tirado and Garcia de la Torre [43]), there are
no reliable values regarding the viscosity of the lipid
interface where the peptide is located, and two peptide
populations, one at the interface and the other in a
transmembrane configuration, are likely to be expected.
The aim of this approach would be to determine whether
the size of the rod would be compatible with the fraction
of alpha helix determined by CD, since from lifetime
data it is difficult to clearly infer about the secondary
structure of the peptide [44].
Although the extent of binding of the S413-PV, reverse
NLS and scrambled peptides to cell membranes is
similar (data not shown), significant differences were
observed in the conformational changes of the three
peptides induced upon their interaction with the neg-
atively charged target membranes. Since the S413-PV
and scrambled peptides exhibit similar propensities to
be arranged as helical structures, as determined by CD
experiments performed in 20% TFE, the distinct pep-
tide conformational changes induced upon interaction
with the negatively charged membranes clearly suggest
that the resulting alpha-helical structure of the S413-
PV peptide is of critical importance for its increased
capacity to translocate across biological membranes, as
compared to the scrambled peptide. Most importantly,
the results demonstrate that the membrane-induced
conformational changes determine the mechanism by
which cellular uptake of the peptide occurs, as revealed
by the distinct subcellular distributions of the three
peptides: the scrambled peptide presented an exclu-
sively punctated cytoplasmic pattern, characteristic of
an endocytic uptake mechanism, whereas the S413-PV
and reverse NLS peptides exhibited mainly a diffuse
subcellular localization, which is consistent with a
membrane translocation process.
In contrast to the scrambled peptide, the S413-PV and
reverse NLS peptides have the capacity to be arranged
as amphipathic alpha helices, namely considering the
13 amino acids derived from the Dermaseptin peptide.
Although this feature is not a requirement for peptide
translocation across the membranes, these structural
motifs can promote local membrane destabilization,
thereby enhancing peptide cellular uptake.
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It was observed that the S413-PV peptide is able to
translocate across biological membranes and accumu-
late inside cells; however, its inability to interact and
partition into neutral model membranes composed of
POPC was very intriguing, since the outer leaflets of
plasma membranes are essentially composed of neu-
trally charged phospholipids. Nonetheless, it is worth
noting two features of biological membranes that may
explain these apparently contradicting observations:
the presence of HSPGs at the cell surface and the exis-
tence of a membrane potential across the lipid bilayer
(negative inside).
Previously, we have demonstrated that the presence
of high negatively charged HSPGs at cell surface
facilitates the cellular uptake of the S413-PV peptide
[22,23]. The results presented here suggest that
HSPGs potentiate peptide binding to cell membranes
through electrostatic interactions, thereby facilitating
the interactions of the peptide with the membranes,
which ultimately lead to peptide insertion into the
lipid bilayer and translocation. On the other hand,
recent studies have demonstrated that the existence
of a transbilayer membrane potential is required for the
cellular uptake of several CPPs [45–48].
In this context, a two-step mechanism could be
invoked for the overall process of peptide translocation
across biological membranes: the interface potential
(i.e. at the membrane–water interface) is the ruling
factor for peptide adsorption at the membrane and is
related to the partition coefficient, at least in this study
where the partition coefficient is negligible in neutral
vesicles; the transbilayer potential (owing to membrane
charge asymmetry) is related to the efficiency of
internalization. In between these two processes, the
peptide undergoes membrane-induced conformational
changes, which are essential for the translocation step.
Irrespective of the primary source of the electrostatic
attraction between the S413-PV peptide and biological
membranes (negatively charged phospholipids, cell
surface proteoglycans, other membrane constituents or
a combination of these), the data presented here clearly
suggest that the electrostatic interaction established
between the S413-PV peptide and biological membranes
is of crucial importance to peptide cellular uptake.
Moreover, our results highlight the relevance of the
sequence of the S413-PV peptide to the establishment
of highly specific peptide–membrane interactions that
occur following its binding to cell membranes, as well as
the importance of the peptide conformational changes
induced by the target membranes to the overall process
of translocation of the S413-PV peptide across biological
membranes.
Acknowledgements
We thank Prof. F. Regateiro, Head of the Centro
de Histocompatibilidade de Coimbra (Portugal), for
scientific collaboration in this study.
This study was supported by a grant from the
Portuguese Foundation for Science and Technology
(POCTI/CVT/44854/2002). M. Mano is a recipient of a
fellowship from the Portuguese Foundation for Science
and Technology.
REFERENCES
1. Langel U. Handbook of Cell Penetrating Peptides. CRC Press: Boca
Raton, FL, 2006.
2. Joliot A, Prochiantz A. Transduction peptides: from technology to
physiology. Nat. Cell. Biol. 2004; 6: 189–196.
3. Snyder EL, Dowdy SF. Recent advances in the use of protein
transduction domains for the delivery of peptides, proteins and
nucleic acids in vivo. Expert Opin. Drug Deliv. 2005; 2: 43–51.
4. Deshayes S, Morris MC, Divita G, Heitz F. Cell-penetrating
peptides: tools for intracellular delivery of therapeutics. Cell. Mol.
Life Sci. 2005; 62: 1839–1849.
5. Mae M, Langel U. Cell-penetrating peptides as vectors for peptide,
protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 2006;
6: 509–514.
6. Lundberg P, Magzoub M, Lindberg M, Hallbrink M, Jarvet J,
Eriksson LE, Langel U, Graslund A. Cell membrane translocation
of the N-terminal (1–28) part of the prion protein. Biochem. Biophys.
Res. Commun. 2002; 299: 85–90.
7. Marinova Z, Vukojevic V, Surcheva S, Yakovleva T, Cebers G,
Pasikova N, Usynin I, Hugonin L, Fang W, Hallberg M,
Hirschberg D, Bergman T, Langel U, Hauser KF, Pramanik A,
Aldrich JV, Graslund A, Terenius L, Bakalkina G. Translocation of
dynorphin neuropeptides across the plasma membrane. A putative
mechanism of signal transmission. J. Biol. Chem. 2005; 280:
26360–26370.
8. De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S,
Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F.
Novel human derived cell penetrating peptides for specific
subcellular delivery of therapeutic biomolecules. Biochem. J. 2005;
390: 407–418.
9. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic
domain rapidly translocates through the plasma membrane and
accumulates in the cell nucleus. J. Biol. Chem. 1997; 272:
16010–16017.
10. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix
of the Antennapedia homeodomain translocates through biological
membranes. J. Biol. Chem. 1994; 269: 10444–10450.
11. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier
for the delivery of biologically active proteins into mammalian cells.
Nat. Biotechnol. 2001; 19: 1173–1176.
12. Lundberg M, Wikstrom S, Johansson M. Cell surface adherence
and endocytosis of protein transduction domains. Mol. Ther. 2003;
8: 143–150.
13. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ,
Chernomordik LV, Lebleu B. Cell-penetrating peptides. A
reevaluation of the mechanism of cellular uptake. J. Biol. Chem.
2003; 278: 585–590.
14. Vives E, Richard JP, Rispal C, Lebleu B. TAT peptide internaliza-
tion: seeking the mechanism of entry. Curr. Protein. Pept. Sci. 2003;
4: 125–132.
15. Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Cher-
nomordik LV. Cellular uptake of unconjugated TAT peptide involves
clathrin-dependent endocytosis and heparan sulfate receptors.
J. Biol. Chem. 2005; 280: 15300–15306.
16. Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giacca M,
Beltram F. Caveolae-mediated internalization of extracellular HIV-
1 tat fusion proteins visualized in real time. Mol. Ther. 2003; 8:
284–294.
17. Fittipaldi A, Ferrari A, Zoppe M, Arcangeli C, Pellegrini V,
Beltram F, Giacca M. Cell membrane lipid rafts mediate caveolar
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2007; 13: 301–313
DOI: 10.1002/psc
INTERACTION OF THE S413-PV PEPTIDE WITH MEMBRANES 313
endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 2003; 278:
34141–34149.
18. Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide
transduction domain enters cells by macropinocytosis. J. Control.
Release 2005; 102: 247–253.
19. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic
peptide enhances escape of TAT-fusion proteins after lipid raft
macropinocytosis. Nat. Med. 2004; 10: 310–315.
20. Foerg C, Ziegler U, Fernandez-Carneado J, Giralt E, Rennert R,
Beck-Sickinger AG, Merkle HP. Decoding the entry of two novel cell-
penetrating peptides in HeLa cells: lipid raft-mediated endocytosis
and endosomal escape. Biochemistry 2005; 44: 72–81.
21. Hariton G, Feder R, Mor A, Graessmann A, Brack W, Jans D,
Gilon C, Loyter A. Targeting of nonkaryophilic cell-permeable
peptides into the nuclei of intact cells by covalently attached
nuclear localization signals. Biochemistry 2002; 41: 9208–9214.
22. Mano M, Teodosio C, Paiva A, Simoes S, Pedroso de Lima MC. On
the mechanisms of the internalization of S4(13)-PV cell penetrating
peptide. Biochem. J. 2005; 390: 603–612.
23. Mano M, Henriques A, Paiva A, Prieto M, Gavilanes F, Simoes S,
Pedroso de Lima MC. Cellular uptake of S4(13)-PV peptide occurs
upon conformational changes induced by peptide-membrane
interactions. Biochim. Biophys. Acta 2006; 1758: 336–346.
24. Bartlett GR. Phosphorus assay in column chromatography. J. Biol.
Chem. 1959; 234: 466–468.
25. Lakowicz JR. Principles of Fluorescence Spectroscopy, (2nd edn).
Kluwer Academic/Plenum Publishers: New York, 1999.
26. De Kroon AI, Soekarjo MW, De Gier J, De Kruijff B. The role
of charge and hydrophobicity in peptide-lipid interaction:
a comparative study based on tryptophan fluorescence
measurements combined with the use of aqueous and hydrophobic
quenchers. Biochemistry 1990; 29: 8229–8240.
27. Coutinho A, Prieto M. Ribonuclease T1 and alcohol dehydrogenase
fluorescence quenching by acrylamide. A laboratory experiment for
undergraduate students. J. Chem. Educ. 1993; 70: 425–428.
28. Loura LM, Fedorov A, Prieto M. Resonance energy transfer in
a model system of membranes: application to gel and liquid
crystalline phases. Biophys. J. 1996; 71: 1823–1836.
29. Marquardt DW. An algorithm for least-squares estimation of non-
linear parameters. J. Soc. Ind. Appl. Math. (SIAM J.) 1963; 11:
431–441.
30. Santos NC, Prieto M, Castanho MA. Quantifying molecular
partition into model systems of biomembranes: an emphasis on
optical spectroscopic methods. Biochim. Biophys. Acta 2003; 1612:
123–135.
31. Marsh D. CRC Handbook of Lipid Bilayers. CRC Press: Boca Raton,
FL, 1990.
32. Willis KJ, Szabo AG. Conformation of parathyroid hormone: time-
resolved fluorescence studies. Biochemistry 1992; 31: 8924–8931.
33. Valeur B, Weber G. Resolution of the fluorescence excitation
spectrum of indole into the 1La and 1Lb excitation bands.
Photochem. Photobiol. 1977; 25: 441–444.
34. Vogel H, Nilsson L, Rigler R, Voges KP, Jung G. Structural
fluctuations of a helical polypeptide traversing a lipid bilayer. Proc.
Natl. Acad. Sci. U.S.A. 1988; 85: 5067–5071.
35. Contreras LM, de Almeida RF, Villalain J, Fedorov A, Prieto M.
Interaction of alpha-melanocyte stimulating hormone with binary
phospholipid membranes: structural changes and relevance of
phase behavior. Biophys. J. 2001; 80: 2273–2283.
36. Lipari G, Szabo A. Effect of librational motion on fluorescence
depolarization and nuclear magnetic resonance relaxation in
macromolecules and membranes. Biophys. J. 1980; 30: 489–506.
37. Kinosita K Jr, Kawato S, Ikegami A. A theory of fluorescence
polarization decay in membranes. Biophys. J. 1977; 20: 289–305.
38. Magzoub M, Kilk K, Eriksson LE, Langel U, Graslund A.
Interaction and structure induction of cell-penetrating peptides
in the presence of phospholipid vesicles. Biochim. Biophys. Acta
2001; 1512: 77–89.
39. Magzoub M, Eriksson LE, Graslund A. Comparison of the
interaction, positioning, structure induction and membrane
perturbation of cell-penetrating peptides and non-translocating
variants with phospholipid vesicles. Biophys. Chem. 2003; 103:
271–288.
40. Thoren PE, Persson D, Esbjorner EK, Goksor M, Lincoln P,
Norden B. Membrane binding and translocation of cell-penetrating
peptides. Biochemistry 2004; 43: 3471–3489.
41. Deshayes S, Heitz A, Morris MC, Charnet P, Divita G, Heitz F.
Insight into the mechanism of internalization of the cell-
penetrating carrier peptide Pep-1 through conformational analysis.
Biochemistry 2004; 43: 1449–1457.
42. Magzoub M, Eriksson LE, Graslund A. Conformational states of
the cell-penetrating peptide penetratin when interacting with
phospholipid vesicles: effects of surface charge and peptide
concentration. Biochim. Biophys. Acta 2002; 1563: 53–63.
43. Tirado MM, Garcia de la Torre J. Translational friction coefficients
of rigid, symmetric top macromolecules. Application to circular
cylinders. J. Chem. Phys. 1979; 71: 2581–2587.
44. Dahms TE, Szabo AG. Probing local secondary structure by
fluorescence: time-resolved and circular dichroism studies of highly
purified neurotoxins. Biophys. J. 1995; 69: 569–576.
45. Terrone D, Sang SL, Roudaia L, Silvius JR. Penetratin and related
cell-penetrating cationic peptides can translocate across lipid
bilayers in the presence of a transbilayer potential. Biochemistry
2003; 42: 13787–13799.
46. Henriques ST, Castanho MA. Consequences of nonlytic membrane
perturbation to the translocation of the cell penetrating peptide
pep-1 in lipidic vesicles. Biochemistry 2004; 43: 9716–9724.
47. Rothbard JB, Jessop TC, Wender PA. Adaptive translocation: the
role of hydrogen bonding and membrane potential in the uptake
of guanidinium-rich transporters into cells. Adv. Drug Deliv. Rev.
2005; 57: 495–504.
48. Bjorklund J, Biverstahl H, Graslund A, Maler L, Brzezinski P. Real-
time transmembrane translocation of penetratin driven by light-
generated proton pumping. Biophys. J. 2006; 91: L29–L31.
Copyright  2007 European Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2007; 13: 301–313
DOI: 10.1002/psc
